JK
Jennifer Kayden Lee sold $8.9M of RYTM stock
Jennifer Kayden Lee, EVP, Head of North America of Rhythm Pharmaceuticals, Inc. (RYTM), sold 75,834 shares of RYTM stock worth $8.9M, per an SEC Form 4 filed Aug 14, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 13, 2026, 1 day before it was made public.
RYTM has moved -3.2% since the trade date, from $116.02 to $112.36 (Nov 20, 2026 close).
- Traded
- Aug 13, 2026
- Disclosed
- Aug 14, 2026
- Filing delay
- 1 day
- Price since
- -3.2%
- Role
- EVP, Head of North America
- Source
- SEC Form 4